2025-02-13 - Analysis Report
## TEM Stock Review: An Unknown Company

**0. Summary of Key Figures:**

* **Cumulative Return (TEM):** 70.07%
* **Cumulative Return (VOO):** 16.37%
* **Return Difference:** 53.7% (71.4% relative to historical range)
* **Current Price:** $73.88
* **5-day MA:** $69.48
* **20-day MA:** $55.87
* **60-day MA:** $48.85
* **RSI:** 75.27
* **PPO:** 2.63
* **Recent Price Change:** +3.75% (significant short-term upward movement)


**1. Performance Comparison:**

TEM, an Unknown Company, has significantly outperformed the S&P 500 (VOO) over the analyzed period.  Its cumulative return of 70.07% is substantially higher than VOO's 16.37%, resulting in a difference of 53.7%.  While the relative divergence suggests the performance is in the upper 71.4% of its historical range, this doesn't guarantee future performance.  The high alpha (59%) and extremely high beta (11.6) suggest high risk and high potential reward.  The CAGR of 75% over 2023-2025 further emphasizes strong growth, though this is likely unsustainable long-term.


**2. Recent Price Movement:**

The current price of $73.88 is above its 5-day, 20-day, and 60-day moving averages, indicating a recent upward trend. The significant daily price increase of 3.75% suggests a possible short-term price surge.


**3. Technical Indicators and Expected Return:**

The RSI of 75.27 suggests the stock is in overbought territory, indicating potential for a short-term correction. The positive PPO (2.63) and the recent 20-day relative divergence increase of 8.7% point to a short-term uptrend.  The high recent price change strengthens this indication of a recent surge. However, the `nan` value for expected return highlights the uncertainty associated with projecting future performance, especially given the high volatility indicated by the beta.  Long-term investment should consider the inherent risks.


**4. Recent Earnings Analysis:**

| Date       | EPS      | Expected EPS |
|------------|----------|--------------|
| 2024-11-04 | -0.25    | -0.26608      |
| 2024-08-06 | -0.63    | -0.59        |

The company has reported negative EPS in the last two quarters, though the negative EPS has been slightly better than expected in both cases.  This suggests possible challenges in profitability that should be further investigated.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue   | Profit Margin |
|---------|-----------|---------------|
| 2024-09-30 | $0.18B   | 58.50%        |
| 2024-06-30 | $0.17B   | 45.50%        |
| 2024-03-31 | $0.15B   | 53.28%        |
| 2023-12-31 | $0.15B   | 55.20%        |
| 2023-09-30 | $0.14B   | 54.41%        |

Revenue has shown a steady increase.  Profit margins are generally high, though they fluctuated in the last two quarters.


**Capital and Profitability:**

| Quarter | Equity    | ROE           |
|---------|-----------|---------------|
| 2024-09-30 | $0.05B   | -141.16%      |
| 2024-06-30 | $0.10B   | -562.04%      |
| 2024-03-31 | $-1.47B  | 4.39%         |
| 2023-12-31 | $-1.38B  | 3.65%         |
| 2023-09-30 | $-1.32B  | 4.03%         |

Negative equity and extremely negative ROE in the last two quarters are extremely concerning and indicate serious financial distress.  This needs urgent attention and investigation.


**6. Overall Analysis:**

TEM shows impressive returns compared to the S&P 500, with high growth and a recent price surge. However, this performance is accompanied by significant risk factors.  The high beta, negative EPS, extremely negative ROE, and negative equity raise serious concerns about the company's financial health and the sustainability of its growth.  The overbought RSI suggests a potential correction. While the short-term outlook might appear positive based on recent price movements and technical indicators,  long-term investment requires a thorough understanding of the underlying business and its financial stability.  Further investigation into the reasons behind the negative equity and ROE is crucial before making any investment decisions.  The extremely high beta suggests high sensitivity to market fluctuations, requiring a risk tolerance for substantial potential losses.
